期刊
PHARMACEUTICALS
卷 3, 期 10, 页码 3343-3354出版社
MDPI
DOI: 10.3390/ph3103343
关键词
adenovirus; pharmaceuticals; microRNA
资金
- Food and Health Bureau [RFCID- 08070082]
- Research Fund for the Control of Infectious Diseases of the Government of Hong Kong, SAR [RFCID- 08070082]
There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据